泌尿外科医生执业结构与前列腺癌诊疗费用
该研究基于2011至2014年20%的按服务付费医保受益人样本,识别新诊断前列腺癌男性及其泌尿外科医生,分析执业结构(多专科团体、单一专科泌尿外科团体规模、调强放疗所有权)与诊断后一年医保支付的关系。多专科团体支付显著低于大型单一专科团体(19181美元 vs 22366美元,P<0.001),拥有调强放疗所有权的执业支付显著高于无所有权者(23801美元 vs 20162美元,P<0.001),敏感性分析结果持续。
要点
- 多专科团体前列腺癌诊疗医保支付低于大型单一专科团体(19181美元 vs 22366美元,P<0.001)。
- 拥有调强放疗所有权的执业支付高于无所有权者(23801美元 vs 20162美元,P<0.001)。
- 泌尿外科医生执业结构与前列腺癌诊疗支付相关。
核心结论
- 泌尿外科医生执业结构与前列腺癌诊疗支付相关,多专科团体每例前列腺癌诊疗的医保支付最低,拥有调强放疗所有权的团体最高。
研究设计与样本
- 使用2011至2014年20%的按服务付费医保受益人样本识别新诊断前列腺癌男性,并通过医疗关系球提供者文件识别每位泌尿外科医生的执业类型、规模和调强放疗所有权。
- 共识别35929名新诊断前列腺癌男性,由6381名泌尿外科医生治疗。
- 拟合广义线性混合模型估计执业特征与诊断后一年医保支付之间的关联,所有模型均调整患者和医疗市场特征。
主要发现
- 多专科团体中新诊断前列腺癌男性的医保支付显著低于大型单一专科团体(19181美元 vs 22366美元,P<0.001)。
- 拥有调强放疗所有权的执业医保支付显著高于无所有权者(23801美元 vs 20162美元,P<0.001)。
- 在仅纳入接受放疗男性及仅分析前列腺癌相关索赔的敏感性分析中,上述差异持续存在。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of urologist practice structure on health care spending for men with prostate cancer. We hypothesize that 3 elements of urologist practice structure may influence spending for prostate cancer care: urologist participation within a multispecialty group (MSG), practice size among single specialty urology groups, and intensity-modulated radiation therapy (IMRT) ownership. MATERIALS AND METHODS: We used a 20% sample of fee-for-service Medicare beneficiaries to identify men newly diagnosed with prostate cancer between 2011 and 2014. We identified each man's urologist and used data from the Healthcare Relational Spheres provider files to identify practice type, size, and IMRT ownership for each urologist. We then fit generalized linear mixed models to estimate the association between these practice features and Medicare payments in the year after diagnosis. All models were adjusted for patient and healthcare market characteristics. RESULTS: We identified 35,929 men with newly diagnosed prostate cancer who were treated by 6381 urologists. Medicare payments for men with newly diagnosed prostate cancer were significantly lower in MSGs ($19,181 v. $22,366 large single specialty group, P < 0.001) and significantly higher among practices with IMRT ownership ($23,801 v. $20,162 for non-owners, P < 0.001). These differences persisted in sensitivity analyses including only men treated with radiotherapy and examining only prostate cancer-related claims. CONCLUSION: Urologist practice structure is associated with payments for prostate cancer care. MSGs had the lowest Medicare payments per episode of prostate cancer care while groups with IMRT ownership had the highest.
引用
- Modi PK, Herrel LA, Kaufman SR, et al. Urologist Practice Structure and Spending for Prostate Cancer Care. Urology. 2019. PMID: 31029672. doi:10.1016/j.urology.2019.03.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。